Instruction for use: Proserin tablets 0.015 g

Active substance: Neostigmine methylsulfate

ATX Code

N07AA01 Neostigmine bromide

Pharmacological group

Cholinesterase inhibitor [m-, n-cholinomimetics, incl. Anticholinesterase drugs]

Composition and form of release

1 ampoule with 1 ml solution for injection contains neostigmine methyl sulfate 0.5 mg; In a cardboard box 10 pcs.

1 tablet contains neostigmine bromide - 15 mg; In a contour acheikova packing 10 pcs., In a cardboard box 2 packs.

pharmachologic effect

Pharmacological action - anticholinesterase, uterotonizing, increasing contractility of smooth muscles.

It blocks cholinesterase, which results in the accumulation of acetylcholine, which excites m- and n-cholinergic receptors.

Indications

Myasthenia gravis, paralysis, poliomyelitis, encephalitis, weakness of labor, atrophy of the optic nerve, neuritis, glaucoma, atony of the stomach, intestines and bladder.

Contraindications

Epilepsy, hyperkinesia, bronchial asthma, angina pectoris, atherosclerosis.

Side effects

Hypersalivation, nausea, vomiting, bradycardia, hypotension, weakness, twitching of the muscles of the tongue, tremor.

Dosing and Administration

P / c - 0.5 mg (1 ml of 0.05% solution) 1-2 times a day; Children - 0.05 mg per year of life, but not more than 0.75 ml of 0.05% solution.

Inside - to 0.015 g 2-3 times a day. Higher doses: single - 0.015 g, daily - 0.05 g. Course - 25-30 days, the interval between courses - 3-4 weeks.

storage Conditions

In the dark place.

Keep out of the reach of children.

Shelf life

Tablets 0.015 g - 5 years.

Injection for 0.05% - 4 years.

Do not use after the expiry date printed on the package.